NTCOC
WST icon

Northern Trust Company of Connecticut’s West Pharmaceutical WST Stock Holding History

Northern Trust Company of Connecticut’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$7.73M Sell
157,598
-19,736
-11% -$924K 0.05% 530
2013
Q3 		$7.3M Sell
177,334
-51,086
-22% -$1.95M 0.05% 553
2013
Q2 		$8.02M Buy
+228,420
New +$7.52M 0.05% 497

Other funds holding WST

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Company of Connecticut's WST Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its West Pharmaceutical (WST) stake by 11% in Q4 2013, selling an estimated $924K and leaving 157,598 shares worth $7.73M. The position accounts for 0.05% of the portfolio, ranked #530.

Northern Trust Company of Connecticut first reported a position in WST in Q2 2013 and has held it in 3 quarters since. The position peaked at $8.02M in Q2 2013. 230 funds tracked by Wall St. Rank hold WST as of Q4 2013.

  • Northern Trust Company of Connecticut held 157,598 shares of West Pharmaceutical worth $7.73M as of Q4 2013.
  • Northern Trust Company of Connecticut sold 19,736 West Pharmaceutical shares in Q4 2013, an estimated $924K.
  • West Pharmaceutical made up 0.05% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #530 holding.
  • Northern Trust Company of Connecticut first reported a position in West Pharmaceutical in Q2 2013 and has held it in 3 quarters since.
  • Northern Trust Company of Connecticut's West Pharmaceutical position peaked at $8.02M in Q2 2013.
  • 230 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.